Viking Global Investors Lp Rayze Bio, Inc. (RYZB) insider trading activity

VIKING GLOBAL INVESTORS LP Transaction History

Date	Transaction	Value	Shares Traded
Feb 26 2024	SELL Other acquisition or disposition	-	6,642,700
Feb 26 2024	SELL Other acquisition or disposition	-	6,642,700
Sep 19 2023	BUY Open market or private purchase	$25,000,002 $18.0 p/Share	1,388,889
Sep 19 2023	BUY Conversion of derivative security	-	5,253,811
Sep 19 2023	BUY Open market or private purchase	$25,000,002 $18.0 p/Share	1,388,889
Sep 19 2023	BUY Conversion of derivative security	-	5,253,811

Also insider at

Wayfair Inc. Consumer Cyclical

> 10% Shareholder

EDIT

Editas Medicine, Inc. Healthcare

> 10% Shareholder

FDC

FIRST DATA CORP

> 10% Shareholder

ABUS

Arbutus Biopharma Corp Healthcare

> 10% Shareholder

MYOV

Myovant Sciences Ltd. Healthcare

> 10% Shareholder

SIOX

Sio Gene Therapies Inc. Healthcare

> 10% Shareholder

UROV

Urovant Sciences Ltd.

> 10% Shareholder

BBIO

BridgeBio Pharma, Inc. Healthcare

ADPT

Adaptive Biotechnologies Corp Healthcare

> 10% Shareholder

DNA

Ginkgo Bioworks Holdings, Inc. Healthcare

ZNTL

Zentalis Pharmaceuticals, Inc. Healthcare

> 10% Shareholder

INBX

Inhibrx, Inc. Healthcare

FDMT

4D Molecular Therapeutics, Inc. Healthcare

RLYB

Rallybio Corp Healthcare

FIGS

FIGS, Inc. Consumer Cyclical

> 10% Shareholder

PRCT

PROCEPT BioRobotics Corp Healthcare

APG

APi Group Corp Industrials

AMLX

Amylyx Pharmaceuticals, Inc. Healthcare

FLAC

Frazier Lifesciences Acquisition Corp Financial Services

ROIV

Roivant Sciences Ltd. Healthcare

VGI